THE IMPACT OF DE NOVO VASCULAR DISEASE IN LIVE DONOR KIDNEY TRANSPLANT RECIPIENTS

被引：0
|
作者：
Lim, W. H. [1 ]
Wong, G. [2 ]
Mainra, R. [1 ]
机构：
[1] Sir Charles Gairdner Hosp, Perth, WA, Australia
[2] Westmead Hosp, Sydney, NSW, Australia
来源：
NEPHROLOGY | 2017年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：42 / 43
页数：2
相关论文
共 50 条
  • [1] Incidence of De Novo Donor Specific Antibodies in Kidney Transplant Recipients
    Staino, C.
    Pilch, N.
    Moussa, O.
    Boyle, K.
    Casale, J.
    Covert, K.
    Fleming, J.
    Taber, D.
    Meadows, H.
    Mardis, C.
    Chavin, K.
    Nadig, S.
    McGillicuddy, J.
    Bratton, C.
    Srinivas, T.
    Baliga, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [2] Outcomes in Kidney Transplant Recipients That Develop De Novo Donor Specific Antibodies
    DeVos, J. M.
    Patel, S. J.
    Land, G.
    Knight, R. J.
    Achkar, K.
    Dilioglou, S.
    Dawson, K. L.
    Abdellatif, A.
    Gaber, A. O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 294 - 294
  • [3] The Impact of Tacrolimus IPV and TTR on the Development of De Novo Donor-specific Antibodies in Kidney Transplant Recipients
    Xu, D.
    Richards, K.
    Zheng, K.
    Patel, H.
    Cardarelli, F.
    Pena, J. A.
    Aala, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 844 - 844
  • [4] IMPACT OF POST-TRANSPLANT TUBERCULOSIS ON LIVE DONOR KIDNEY TRANSPLANT RECIPIENTS: RISK FACTORS AND OUTCOME
    Elshahat, Samar
    El Wasif, Salwa
    Omar, Essam Lotfy
    Al-Barshomy, Said M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [5] DE NOVO INFLAMMATORY BOWEL DISEASE IN KIDNEY TRANSPLANT RECIPIENTS - REPORT OF THREE CASES
    Obrencevic, Katarina
    Vavic, Neven
    Petrovic, Marijana
    Petrovic, Stanko
    Tufegdzic, Ivana
    Rabrenovic, Violeta
    Maksic, Djoko
    Tadic, Jelena
    Pilcevic, Dejan
    TRANSPLANT INTERNATIONAL, 2019, 32 : 421 - 421
  • [6] IMPACT OF DE NOVO DONOR SPECIFIC ANTIBODY ACCORDING TO THE TRANSPLANT TYPE IN KIDNEY TRANSPLANTATION
    Park, Woo Yeong
    Kim, Yaerim
    Paek, Jin Hyuk
    Jin, Kyubok
    Roh, Young-Nam
    Han, Seungyeup
    TRANSPLANT INTERNATIONAL, 2021, 34 : 290 - 291
  • [7] ASKP1240 in De Novo Kidney Transplant Recipients
    Harland, R.
    Klintmalm, G.
    Yang, H.
    Jensik, S.
    Shah, T.
    West-Thielke, P.
    Shihab, F.
    Zhang, W.
    Santos, V.
    Tainaka, R.
    Wang, X.
    First, R.
    Holman, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [8] Association of prevalent vascular disease with allograft failure and mortality in live-donor kidney transplant recipients - a retrospective cohort study
    Mainra, Rahul
    Wong, Germaine
    Pilmore, Helen
    Lim, Wai H.
    TRANSPLANT INTERNATIONAL, 2019, 32 (11) : 1161 - 1172
  • [9] Incidence of De Novo Donor Specific Antibodies and Treatment Response for AMR in Pediatric Kidney Transplant Recipients
    Gattis, S.
    Liverman, R.
    Serluco, A.
    Yin, J.
    Sullivan, H. C.
    Bray, R. A.
    Gebel, H. M.
    Jernigan, S.
    George, R.
    Winterberg, P. D.
    Garro, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1065 - 1066
  • [10] COMPARISON OF DE NOVO DONOR SPECIFIC ANTIBODY FORMATION FOR KIDNEY TRANSPLANT RECIPIENTS INDUCED WITH THYMOGLOBULIN OR BASILIXIMAB
    Qazi, Yasir
    Gong, Alex
    Lee, Kristina
    Smogorzewski, Mirosolaw
    TRANSPLANT INTERNATIONAL, 2017, 30 : 531 - 531
12345